Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 17 Nov 2021 for Allena Pharmaceuticals, Inc., €29k.
Filing timeline
BuySaleLouis Brenner MD
Insider track record
Disclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Louis Brenner MD: trading record in brief
Louis Brenner MD discloses dealings in 2 companies, chiefly AMAG Pharmaceuticals Inc. and Allena Pharmaceuticals, Inc. We count 31 filings; the first trade dates from 3 October 2007 and the latest from 15 November 2021.
The open-market record consists of 17 sales worth €719k, with no purchase. Besides market trades, the filings include 1 share grant and 13 option exercises. So far in 2021, the count stands at no purchases and 2 sales.
On 17 November 2021 came the latest disclosure, an option exercise in Allena Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Louis Brenner MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
40,328 shares@ US$0.8155.3% of flowCommon StockSEC:0001209191-21-065147:0
25,215 shares@ US$1.1144.7% of flowCommon StockSEC:0001209191-21-032076:0
2 of 2 declarations
